Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis

Arthritis and Rheumatism

Volumn 62, Issue 11, 2010, Pages 3259-3264

  Giannini, Edward H ^a   Ilowite, Norman T ^b   Lovell, Daniel J ^a   Wallace, Carol A ^c   Rabinovich, C Egla ^d   Reiff, Andreas ^e   Higgins, Gloria ^f   Gottlieb, Beth ^g   Chon, Yun ^h   Zhang, Nan ^h   Baumgartner, Scott W ^h  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e CHILDREN S HOSPITAL LOS ANGELES   (United States)

^f OHIO STATE UNIVERSITY   (United States)

^g SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^h AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; FOLIC ACID; FOLINIC ACID; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ADOLESCENT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CHILD GROWTH; CLINICAL TRIAL; DRUG EFFECT; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT DURATION;

ADOLESCENT; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CHILD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; METHOTREXATE; RECEPTORS, TUMOR NECROSIS FACTOR; REGISTRIES; TREATMENT OUTCOME;

EID: 78249250295     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27682     Document Type: Article

References (15)

1. Seid M, Opipari L, Huang B, Brunner HI, Lovell DJ,. Disease control and health-related quality of life in juvenile idiopathic arthritis. Arthritis Rheum 2009; 61: 393 - 9.
2. Polito C, Strano CG, Olivieri AN, Alessio M, Iammarrone CS, Todisco N, et al. Growth retardation in non-steroid treated juvenile rheumatoid arthritis. Scand J Rheumatol 1997; 26: 99 - 103.
3. Borchers AT, Selmi C, Cheema G, Keen CL, Shoenfeld Y, Gershwin ME,. Juvenile idiopathic arthritis. Autoimmun Rev 2006; 5: 279 - 98.
4. Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, et al, for the Pediatric Rheumatology Collaborative Study Group. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 2000; 342: 763 - 9.
5. Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M, et al. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 2003; 48: 1093 - 101.
6. Horneff G, De Bock F, Foeldvari I, Girschick HJ, Michels H, Moebius D, et al, and the German and Austrian Paediatric Rheumatology Collaborative Study Group. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry. Ann Rheum Dis 2009; 68: 519 - 25.
7. Tynjala P, Lahdenne P, Vahasalo P, Kautiainen H, Honkanen V,. Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis. Ann Rheum Dis 2006; 65: 1044 - 9.
8. Vojvodich PF, Hansen JB, Andersson U, Savendahl L, Hagelberg S,. Etanercept treatment improves longitudinal growth in prepubertal children with juvenile idiopathic arthritis. J Rheumatol 2007; 34: 2481 - 5.
9. Schmeling H, Seliger E, Horneff G,. Growth reconstitution in juvenile idiopathic arthritis treated with etanercept. Clin Exp Rheumatol 2003; 21: 779 - 84.
10. Giannini EH, Ilowite NT, Lovell DJ, Wallace CA, Rabinovich CE, Reiff A, et al. Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis. Arthritis Rheum 2009; 60: 2794 - 804.
11. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390 - 2.
12. Centers for Disease Control and Prevention. CDC growth charts. URL:.
13. Tanner JM, Whitehouse RH,. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976; 51: 170 - 9.
14. Saha MT, Verronen P, Laippala P, Lenko HL,. Growth of prepubertal children with juvenile chronic arthritis. Acta Paediatr 1999; 88: 724 - 8.
15. Packham JC, Hall MA,. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatology (Oxford) 2002; 41: 1428 - 35.